Lyme Vaccine And Elisa

Labcold 543L Pharmacy and Vaccine Refrigerator
RLDF1819 Scientific Laboratory Supplies EACH 4623.6 EUR

Elisa Lyme Laboratories manufactures the lyme vaccine and elisa reagents distributed by Genprice. The Lyme Vaccine And Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact elisa lyme. Other Lyme products are available in stock. Specificity: Lyme Category: Vaccine Group: And Elisa

True Blue
TargetMol Chemicals 10mg Ask for price
Description: True Blue

True Blue
TargetMol Chemicals 1g Ask for price
Description: True Blue

True Blue
TargetMol Chemicals 1mg Ask for price
Description: True Blue

True Blue
TargetMol Chemicals 50mg Ask for price
Description: True Blue

True Blue
TargetMol Chemicals 5mg Ask for price
Description: True Blue

Human Lyme Disease PB
AcceGen 1 pack Ask for price
Description: Lyme disease is caused by four main species of bacteria: Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii bacteria. The most common tick-borne illness in these regions, Lyme disease is transmitted by the bite of an infected black-legged tick, commonly known as a deer tick.

Recombinant Lyme Disease Antigen
EnoGene 100ug 695 EUR

And Elisa information

Pam3CSK4 vaccine adjuvant; FITC labelled
AV-9025-F Alpha Diagnostics 100 ug 416.4 EUR

Pertussis Toxin B.Pertussis, vaccine grade
AV-9130-50 Alpha Diagnostics 50 ug 634.8 EUR

Peptidoglycan (S. aureus); vaccine adjuvant
AV-7045-25 Alpha Diagnostics 25 mg 1220.4 EUR

Peptidoglycan (S. aureus); vaccine adjuvant
AV-7045-5 Alpha Diagnostics 5 mg 343.2 EUR

Bordetella bronchiseptica proteins (inactivated vaccine for dog) for ELISA
BBV15-N-100 Alpha Diagnostics 100 ug 343.2 EUR

SARS-CoV-2 Spike Trimer (XBB.1.5) ELISA Kit (For Vaccine Development)
RAS-A145 ACROBIOSYSTEMS 96tests 845.3 EUR
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (XBB.1) ELISA Kit (For Vaccine Development)
RAS-A149 ACROBIOSYSTEMS 96tests 845.3 EUR
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike Trimer is urgently needed to accelerate the development of COVID-19 vaccines.

ID-VAC Human Influenza A Vaccine identification ELISA kit, 24 tests
920-FLA-VID-24 Alpha Diagnostics 1 Kit 634.8 EUR

Pam3CSK4 vaccine adjuvant; Biotin labelled
AV-9025-B Alpha Diagnostics 100 ug 416.4 EUR

Pam2CSK4 vaccine adjuvant; Biotin conjugate
AV-9020-B Alpha Diagnostics 1 mg 489.6 EUR

Pam2CSK4 vaccine adjuvant; Biotin conjugate
AV-9020-B-100 Alpha Diagnostics 100 ug 196.8 EUR

SARS-CoV-2 Spike S1 (B.1.1.529) Specific ELISA Kit (For Vaccine Development)
RAS-A170 ACROBIOSYSTEMS 96tests 845.3 EUR
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike S1 is urgently needed to accelerate the development of COVID-19 vaccines.

HER2 peptide, (369 ?377), E75 vaccine candidate
HER2-369-P Alpha Diagnostics 5 mg 416.4 EUR

HER2 peptide, (654 ? 662), GP2 vaccine candidate
HER2-654-P Alpha Diagnostics 5 mg 416.4 EUR

Single Donor Human SARS-CoV-2 Negative Vaccine And First Booster Positive Immunocompromised Serum
ISERSCOV2VNP1BPIMCMP Innovative research each 209 EUR
Description: Single Donor Human SARS-CoV-2 Negative Vaccine And First Booster Positive Immunocompromised Serum

Single Donor Human SARS-CoV-2 Negative Vaccine And First Booster Positive Immunocompromised Plasma
IPLASCOV2VNP1BPIMCMP Innovative research each 209 EUR
Description: Single Donor Human SARS-CoV-2 Negative Vaccine And First Booster Positive Immunocompromised Plasma

SARS-CoV-2 Spike RBD (B.1.1.529) Specific ELISA Kit (For Vaccine Development)
RAS-A082 ACROBIOSYSTEMS 96tests 845.3 EUR
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.